Special Report: The Peptide-Oligonucleotide Partnership

Molecular biology has come a long way in the nearly 40 years since James Watson and Francis Crick published their classic paper on the three-dimensional structure of DNA (Nature, 171:737-738, 1953). Since then, the intimate relationship between nucleic acids and proteins has not only been deciphered, but also harnessed and manipulated to fuel a whole new industry. Armed with sophisticated equipment, today's molecular biologists can easily extract, purify, and sequence DNA, RNA, and proteins, a

Written byHolly Ahern
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Molecular biology has come a long way in the nearly 40 years since James Watson and Francis Crick published their classic paper on the three-dimensional structure of DNA (Nature, 171:737-738, 1953). Since then, the intimate relationship between nucleic acids and proteins has not only been deciphered, but also harnessed and manipulated to fuel a whole new industry.

Armed with sophisticated equipment, today's molecular biologists can easily extract, purify, and sequence DNA, RNA, and proteins, and even create short stretches of DNA bases (oligonucleotides) and short proteins (peptides) to their own specifications. The effects of these new developments have reverberated far beyond the biochemical research arena to such diverse fields as agriculture, horticulture, human and veterinary medicine, and forensics.

The functional connections among DNA, proteins, and traits began to be unraveled in 1909, when English physician Archibald Garrod established a key link between what he called "inborn errors of metabolism" (such ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies